药品行政保护
药品行政保护-
药品行政保护品种介绍：生物医学技术药物
Product brief of administrative protection of pharmaceuticals : biomedical technology drugs
-
药品行政保护品种介绍：呼吸系统药
Product brief of administrative protection of pharmaceuticals : respiratory system agents
-
药品行政保护品种介绍&心血管系统药物（二）（续一）
Product brief of administrative protection of pharmaceuticals : cardiovascular drugs ( 2 )
-
药品行政保护品种介绍：抗感染药（一）（待续）
Product brief of administrative protection of pharmaceuticals : anti-infective agents ( 1 )( continuation )
-
药品行政保护品种介绍：其他类药品（六）（续五）
Product brief of administrative protection of pharmaceuticals : other agents ( 6 ) ( continuation 5 );
-
药品行政保护品种介绍：甾体药物（三）（续二）
Product brief of administrative protection of pharmaceuticals : steroidal agents ( 3 ) ( continuation 2 );
-
药品行政保护品种介绍：神经系统与精神药物（五）（续完）
Product brief of administrative protection of pharmaceuticals : nervous system and psychotropic drugs ( 5 )( end )
-
方法：从创新药物研发与专利保护、药品的行政保护与专利保护、专利文献信息、专利战略与专利人才等方面，分析我国制药企业面临的专利问题。
METHODS : Patents problems confronted by Chinese pharmaceutical enterprises were analyzed in terms of the research and development and patent protection of the original new drugs , the administrative protection and patent protection of drugs , patent documentation in ˉ formation , patent strategy and patent talents , etc.
-
我国先后与美国、欧盟、日本等国家签订了关于药品保护的双边协议，建立了药品行政保护制度。
China has signed the bilateral agreements about the administrative protection of medicine with the United States , the European Union countries and other countries and established an administrative protection system for medicine .
-
国家药品监督管理局（SDA）负责药品的行政保护；
The State Drug Administration (" SDA ") was responsible for administrative protection of pharmaceuticals ;